Derval O'Carroll
Compliance Officer en INFLARX N.V. .
Fortuna: - $ al 31/03/2024
Perfil
Derval O'Carroll is currently the SVP, Head-Global Regulatory Affairs & Compliance at InflaRx NV.
Previously, she worked as the Senior Director-Regulatory Affairs at Travere Therapeutics, Inc. from 2015 to 2017.
She also held the position of Head-Regulatory Affairs at Amryt Pharma Holdings Ltd.
and Amryt Pharma Plc.
Ms. O'Carroll completed her graduate studies and earned an MBA from University College Dublin.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
INFLARX N.V.
-.--% | 31/12/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Derval O'Carroll
Empresas | Cargo | Inicio |
---|---|---|
INFLARX N.V. | Compliance Officer | 01/01/2022 |
Antiguos cargos conocidos de Derval O'Carroll.
Empresas | Cargo | Fin |
---|---|---|
TRAVERE THERAPEUTICS, INC. | General Counsel | 01/12/2017 |
AMRYT PHARMA PLC | General Counsel | - |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | General Counsel | - |
Formación de Derval O'Carroll.
University College Dublin | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
TRAVERE THERAPEUTICS, INC. | Health Technology |
INFLARX N.V. | Health Technology |
Empresas privadas | 2 |
---|---|
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Amryt Pharma Plc
Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Amryt Pharma Plc operates as a holding company with interests in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. The company was founded on July 17, 2019 and is headquartered in Dublin, Ireland. | Health Technology |
- Bolsa de valores
- Insiders
- Derval O'Carroll